What to Know About Weight-Loss Drugs and Sleep Apnea
by CNET
CNET— Zepbound, a drug that rivals Ozempic, may one day be a treatment for sleep apnea, according to results from a new study.
Fast Company—Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here's what you need to know. Metsera, a clinical-stage biotechnology startup that develops drugs for obesity and metabolic diseases, launched on Thursday with what it described as a “broad portfolio” of weight-loss treatments that it hopes to bring to market. The company, which has already acquired the U.K.-based startup, Zihipp, and formed a licensing pact with a South Korean drugmaker, D&D Pharmatech, claims that its products could eventually compete with industry leaders Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro....
Fast Company—How weight-loss drugs are changing the diet industry. Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his thirties to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame. A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising—the habits behind many commercial diet...
Yle Uutiset—Kela eyes ballooning cost of weight loss drugs. Finland has seen a surge in demand for popular anti-obesity medications.